The Treatment Action Campaign (TAC) and the AIDS Law Project (ALP) are concerned by reports of violence and intimidation against members of the Abahlali baseMjondolo Movement (ABM) in the Kennedy Road informal settlement in Durban. ABM is a community based organisation that works to improve conditions for shack dwellers.
According to a statement released by several civil society groups, local ANC people allegedly drove leaders of the ABM and others out of the settlement. We have received further reports that the people carrying out the attacks sang anti Mpondo slogans and that the...Read more
The draft Preferential Procurement Regulations (“the draft regulations”) were published for public comment on 14 August 2009. The AIDS Law Project (ALP), a not-for-profit organisation that seeks to use and develop the law to defend and advance constitutionally protected rights, has a direct interest in the draft regulations. This arises out of ALP’s work on access to medicines – an integral part of the right to have access to health care services – and the manner in which the state procures antiretroviral (ARV) medicines. ALP has submitted a document with recommendations in respect to the...Read more
By Mark Heywood, Director of the AIDS Law Project
Last week the great and good of the South African private health industry and the national Health Department gathered for four days at Sun City to deliberate on the future of health care and the proposed system of National Health Insurance (NHI). They started their conference with a golf day and ended with a banquet, dress: ‘black tie or traditional’. Whilst the pro- and not-so-sure NHI’ers differed on the conference floor, they mixed easily on the dance floor.
Intense debates about the future health system took place, with...Read more
GlaxoSmithKline (GSK), one of the world's largest pharmaceutical developers, and Aspen Pharmacare, South Africa's largest generic pharmaceutical manufacturer, intend to merge their South African operations. As part of the merger, most of GSK's South African operations will become part of Aspen. GSK will purchase 16% of Aspen's shares and become the company's single-largest shareholder.
Following submissions and correspondence from the Treatment Action Campaign (TAC), the Centre for the AIDS Programme of Research (CAPRISA) and the Southern African HIV Clinicians Society (SAHCS),...Read more